Evidence map›Paper›PMID 37901510›Full record

ArticleACS omega2023

Development of

Jose F Camacaro, Christopher P Dunckley, S Elizabeth Harman, Hilary A Fitzgerald, Andrew L Lakes, Zuolei Liao, Russell C Ludwig, Katie M McBride, Ezgi Yalcintas Bethune, Ali Younes and 2 more

Abstract read
In one paragraph

Article in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Measurement ofACS omega · 2025
    Article
  5. Six degrees of actinide separation.Nature reviews. Chemistry · 2024
    Article
  6. Review
  7. Targeted Alpha Therapy: All We Need to Know aboutPharmaceuticals (Basel, Switzerland) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jose F CamacaroTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.ORCID https://orcid.org/0009-0008-2795-218X
Christopher P DunckleyTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
S Elizabeth HarmanTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Hilary A FitzgeraldTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Andrew L LakesTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Zuolei LiaoTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Russell C LudwigTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Katie M McBrideTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Ezgi Yalcintas BethuneTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Ali YounesTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.
Sayandev ChatterjeeTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.ORCID https://orcid.org/0000-0003-2218-5635
Laura M LilleyTerraPower LLC, 15800 Northup Way, Bellevue, Washington 98008, United States.ORCID https://orcid.org/0000-0003-3169-3703

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The promise of

Identifiers

PMID37901510
PMCPMC10601055

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.